For many years, GLP-1 receptor agonists have been largely considered anti-diabetic drugs. But, the perception has been c...

Long COVID remains one of the most clinically controversial post-viral conditions even after the acute phase of COVID-19...

The use of AI in radiology has changed dramatically in the past few years, and the discussion for the upcoming years &nd...

The gut microbiome has become one of the most commercially discussed areas in modern medicine, with increasing claims li...

The rapid success of mRNA vaccines during the COVID-19 pandemic transformed public and scientific perception of messenge...